{
    "clinical_study": {
        "@rank": "154625", 
        "acronym": "Advanced", 
        "arm_group": [
            {
                "arm_group_label": "Tegaderm HP", 
                "description": "Patients whose intravasculare devices dressings are made exclusevely with Tegaderm HP dressings."
            }, 
            {
                "arm_group_label": "Advanced", 
                "description": "Patients whose intravasculare devices dressings are made exclusevely with Advanced dressings"
            }
        ], 
        "brief_summary": {
            "textblock": "Intravascular devices in intensive care units are often associated to complications. The\n      investigators estimate that 23.5% of catheters placed and used in intensive care are subject\n      to at least one complication; the goal is to demonstrate the effectiveness of the new\n      Tegaderm \u2122 IV Advanced dressings to achieve a decrease of 35% in the number of complications\n      associated with intravascular catheters in intensive care."
        }, 
        "brief_title": "Comparison of Two New Generations Dressings in Intensive Care Unit", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Catheter Related Complications", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients over 18 years with a central venous catheter, an arterial catheter, a\n             hemodialysis catheter, a Swan Ganz catheter or a peripheral catheter inserted in the\n             ICU or within the 24 before their arrival at the ICU in another ICU setting.\n\n          -  Patients benefiting from the social security protection.\n\n        Exclusion Criteria:\n\n          -  Patients under 18 years of age,\n\n          -  Patients having known allergy or sensitivity to adhesive dressing materials"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients hospitalised in the Medical ICU and requiring an intravascular device during\n        hospitalisation (peripheral or central)"
            }
        }, 
        "enrollment": {
            "#text": "685", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01795391", 
            "org_study_id": "ADVANCED"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Prevention", 
            "Dressings", 
            "Catheters"
        ], 
        "lastchanged_date": "January 20, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Grenoble", 
                    "country": "France", 
                    "state": "Is\u00e8re", 
                    "zip": "38043"
                }, 
                "name": "University Hospital of Grenoble, Medical Intensive Care Unit"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "2", 
        "official_title": "Comparison Between Two New Generation Dressings in the Prevention of Intravascular Catheter Related Complications in Intensive Care Units", 
        "other_outcome": [
            {
                "measure": "Number of participants presenting allergic adverse events.", 
                "safety_issue": "No", 
                "time_frame": "From the insertion of the catheter to its removal, an average time frame thant can go up to 4 weeks."
            }, 
            {
                "measure": "Cost of each dressing type strategy.", 
                "safety_issue": "No", 
                "time_frame": "From the insertion of the catheter to its removal, an average time frame thant can go up to 4 weeks."
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number of catheters presenting any kind of complications.", 
            "safety_issue": "No", 
            "time_frame": "From the insertion of the catheter to its removal, an average time frame thant can go up to 4 weeks."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01795391"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Number of infections related to poor adherent dressings.", 
            "safety_issue": "No", 
            "time_frame": "From the insertion of the catheter to its removal, an average time frame thant can go up to 4 weeks."
        }, 
        "source": "University Hospital, Grenoble", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Grenoble", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}